Tianjin First Central Hospital
52
7
7
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.9%
1 terminated/withdrawn out of 52 trials
91.7%
+5.1% vs industry average
12%
6 trials in Phase 3/4
9%
1 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (52)
Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT
Role: lead
Immunity in Critical Sepsis
Role: collaborator
NK Cells Plus ICI for SCLC Maintenance
Role: lead
Coronary Crossing System in Patients With Coronary Chronic Total Occlusions
Role: collaborator
Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide
Role: collaborator
Investigator-Initiated Study of BBM-C101 Injection in Subjects With HPV16/18 Infection
Role: lead
Sepsis in Critically Ill Patients
Role: collaborator
Nimotuzumab Combined With the Stupp Regimen for Postoperative Residual Glioblastoma
Role: lead
YH02 Injection for Intra-tumor Injection Therapy in Advanced Solid Tumors With Unresponsive or Failure-Treated Cases
Role: lead
Effect of Liposomal Bupivacaine TAPB Combined With Oxycodone PCIA on Postoperative Gastrointestinal Recovery in Patients Undergoing Major Abdominal Surgery
Role: lead
Acute Kidney Injury in Critically Ill Patients
Role: collaborator
Clinical Study on the Efficacy and Safety of Nalfurafine Hydrochloride Orally Disintegrating Tablets in Treating Pruritus in Patients Undergoing Maintenance Hemodialysis
Role: collaborator
Efficacy of Liposomal Bupivacaine for Transversus Abdominis Plane Block
Role: lead
Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy
Role: collaborator
Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab
Role: collaborator
to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection
Role: collaborator
Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial
Role: collaborator
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Role: collaborator
A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
Role: lead
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
Role: collaborator